Ingevity (NGVT) reported $1.2B in revenue for fiscal 2025, −2.7% year on year. That ranks #1687 by revenue among 2853 SEC filers and #128 in Materials. It posted a net loss of −$167M for the same year. Revenue has grown 2.8% a year on average since 2016 ($908M then). The fiscal 2025 balance sheet shows $1.7B in total assets, $78.1M in cash and $1.2B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.2B | −2.7% | FY20252025-12-31 |
| Gross profitGrossProfit | $462M | −0.7% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $419M | −1.7% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$167M | +$263M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $331M | +157.5% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquireProductiveAssets | $57.7M | −25.6% | FY20252025-12-31 |
| Total assetsAssets | $1.7B | −18.4% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $29.7M | −84.8% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $78.1M | +14.9% | FY20252025-12-31 |
| Long-term debtLongTermDebtAndCapitalLeaseObligations | $1.2B | −13.3% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $258M | $59.8M | Open → |
| Q2 20262026-06-30 | $314M | $35.3M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 127 of 134 companies compared | −14.3% | |
| Operating marginRank 12 of 131 companies compared | 35.9% | |
| R&D as share of revenueRank 17 of 75 companies compared | 2.4% | |
| Cash as share of revenueRank 81 of 132 companies compared | 6.7% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Ingevity Corp
- Ticker
- NGVT
- Exchange
- NYSE
- SIC classification
- Chemicals & Allied Products (2800)
- Fiscal year end
- 12-31
- CIK
- 0001653477
Filings
- 10-QJul 30, 2026Open filing →
- 10-QMay 7, 2026Open filing →
- 10-KFeb 26, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Allied GoldAAUC | $1.3B | −$51.8M |
| First Majestic SilverAG | $1.3B | $165M |
| Compass Minerals InternationalCMP | $1.2B | −$79.8M |
| IngevityNGVT | $1.2B | −$167M |
| Westlake Chemical PartnersWLKP | $1.2B | $48.7M |
| MetallusMTUS | $1.2B | −$1.2M |
| EnproNPO | $1.1B | $40.5M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ingevity — Key figures |url=https://companiesranked.com/en/company/ingevity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ingevity — Key figures. CompaniesRanked. https://companiesranked.com/en/company/ingevityBibTeX
@misc{companiesranked-en-company-ingevity-2026,
author = {{CompaniesRanked}},
title = {{Ingevity — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ingevity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001653477-26-000014 · February 26, 2026
{{cite web |title=Ingevity — Key figures — 10-K (0001653477-26-000014) |url=https://www.sec.gov/Archives/edgar/data/1653477/000165347726000014/ngvt-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.